» Articles » PMID: 19490125

Functional Role of the Linker Region in Purified Human P-glycoprotein

Overview
Journal FEBS J
Specialty Biochemistry
Date 2009 Jun 4
PMID 19490125
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Human P-glycoprotein (P-gp), which conveys multidrug resistance, is an ATP-dependent drug efflux pump that transports a wide variety of structurally unrelated compounds out of cells. P-gp possesses a 'linker region' of approximately 75 amino acids that connects two homologous halves, each of which contain a transmembrane domain followed by a nucleotide-binding domain. To investigate the role of the linker region, purified human P-gp was cleaved by proteases at the linker region and then compared with native P-gp. Based on a verapamil-stimulated ATP hydrolase assay, size-exclusion chromatography analysis and a thermo-stability assay, cleavage of the P-gp linker did not directly affect the preservation of the overall structure or the catalytic process in ATP hydrolysis. However, linker cleavage increased the k(cat) values both with substrate (k(sub)) and without substrate (k(basal)), but decreased the k(sub)/k(basal) values of all 10 tested substrates. The former result indicates that cleaving the linker activates P-gp, while the latter result suggests that the linker region maintains the tightness of coupling between the ATP hydrolase reaction and substrate recognition. Inspection of structures of the P-gp homolog, MsbA, suggests that linker-cleaved P-gp has increased ATP hydrolase activity because the linker interferes with a conformational change that accompanies the ATP hydrolase reaction. Moreover, linker cleavage affected the specificity constants [k(sub)/K(m(D))] for some substrates (i.e. linker cleavage probably shifts the substrate specificity profile of P-gp). Thus, this result also suggests that the linker region regulates the inherent substrate specificity of P-gp.

Citing Articles

ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.

Elbahnsi A, Dudas B, Callebaut I, Hinzpeter A, Miteva M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770445 PMC: 11676857. DOI: 10.3390/ph17121602.


Structural View of Cryo-Electron Microscopy-Determined ATP-Binding Cassette Transporters in Human Multidrug Resistance.

Fan W, Shao K, Luo M Biomolecules. 2024; 14(2).

PMID: 38397468 PMC: 10886794. DOI: 10.3390/biom14020231.


Cross-Linking Mass Spectrometry on P-Glycoprotein.

Gellen G, Klement E, Biwott K, Schlosser G, Kallo G, Csosz E Int J Mol Sci. 2023; 24(13).

PMID: 37445813 PMC: 10341432. DOI: 10.3390/ijms241310627.


A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance.

Huang J, Ecker G Molecules. 2023; 28(2).

PMID: 36677553 PMC: 9862083. DOI: 10.3390/molecules28020495.


Structure-based alteration of tryptophan residues of the multidrug transporter CmABCB1 to assess substrate binding using fluorescence spectroscopy.

Inoue Y, Yamaguchi T, Otsuka T, Utsunomiya Y, Pan D, Ogawa H Protein Sci. 2022; 31(6):e4331.

PMID: 35634783 PMC: 9123602. DOI: 10.1002/pro.4331.